ADAMS ERIC A
SEC CIK 1817882 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INM | InMed Pharmaceuticals Inc. | Pres, CEO, Dir | 44.0K | $70.0K | — | 5 | 2021-09-28 | 2024-02-20 |
Most active insiders at INM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ADAR1 Capital Management, LLC | 10% | $841.2K | — |
| 2 | Vivo Opportunity, LLC | 10% | $433.5K | — |
ADAMS ERIC A made no open-market trades at INM in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-21 | 2024-02-20 | INM | InMed Pharmaceuticals Inc. | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $0.36 | +41.6K | 44.0K | +1,763% | +$15.0K | |
| 2022-04-18 | 2022-04-14 | INM | InMed Pharmaceuticals Inc. | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $0.89 | +14.2K | 59.0K | +32% | +$12.6K | |
| 2022-04-13 | 2022-04-13 | INM | InMed Pharmaceuticals Inc. | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $0.85 | +8,560 | 44.8K | +24% | +$7,276 | |
| 2021-09-30 | 2021-09-29 | INM | InMed Pharmaceuticals Inc. | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $1.73 | +8,800 | 36.3K | +32% | +$15.2K | |
| 2021-09-29 | 2021-09-28 | INM | InMed Pharmaceuticals Inc. | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $1.75 | +11.4K | 27.5K | +71% | +$19.9K |
Purchase Sale Sale after option exercise All abbreviations